Jonathan Block
Stock Analyst at Stifel
(4.23)
# 355
Out of 5,182 analysts
227
Total ratings
53.09%
Success rate
14.34%
Average return
Main Sectors:
Stocks Rated by Jonathan Block
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BBNX Beta Bionics | Maintains: Buy | $22 → $20 | $10.08 | +98.41% | 5 | Apr 22, 2026 | |
| NYXH Nyxoah | Maintains: Buy | $10 → $8 | $3.01 | +165.78% | 13 | Apr 10, 2026 | |
| INSP Inspire Medical Systems | Maintains: Buy | $85 → $70 | $55.11 | +27.02% | 16 | Apr 10, 2026 | |
| TRUP Trupanion | Maintains: Hold | $35 → $31 | $24.96 | +24.20% | 18 | Mar 31, 2026 | |
| IDXX IDEXX Laboratories | Maintains: Buy | $775 → $675 | $568.30 | +18.78% | 24 | Mar 31, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Hold | $20 → $22 | $18.63 | +18.09% | 3 | Feb 20, 2026 | |
| ALGN Align Technology | Maintains: Buy | $200 → $210 | $177.28 | +18.46% | 41 | Feb 5, 2026 | |
| PODD Insulet | Maintains: Buy | $370 → $350 | $182.87 | +91.39% | 2 | Feb 4, 2026 | |
| RMD ResMed | Maintains: Hold | $260 → $265 | $217.14 | +22.04% | 5 | Jan 30, 2026 | |
| COO The Cooper Companies | Reiterates: Buy | $85 → $95 | $63.09 | +50.58% | 20 | Dec 5, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $140 → $130 | $116.65 | +11.44% | 24 | Nov 18, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Hold | $9 | $7.18 | +25.35% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reinstates: Buy | $85 | $59.32 | +43.29% | 1 | Oct 21, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $23 | $22.15 | +3.84% | 15 | Sep 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $19 → $17 | $11.78 | +44.31% | 13 | Aug 8, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Hold | $80 → $75 | $76.12 | -1.47% | 7 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $23.32 | -35.68% | 5 | Feb 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $4 → $2 | $0.84 | +139.38% | 5 | Jul 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $17 | $3.01 | +464.78% | 1 | Nov 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $5 → $4 | $1.05 | +280.95% | 3 | May 12, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Hold | $32 → $35 | $119.63 | -70.74% | 5 | Aug 3, 2018 |
Beta Bionics
Apr 22, 2026
Maintains: Buy
Price Target: $22 → $20
Current: $10.08
Upside: +98.41%
Nyxoah
Apr 10, 2026
Maintains: Buy
Price Target: $10 → $8
Current: $3.01
Upside: +165.78%
Inspire Medical Systems
Apr 10, 2026
Maintains: Buy
Price Target: $85 → $70
Current: $55.11
Upside: +27.02%
Trupanion
Mar 31, 2026
Maintains: Hold
Price Target: $35 → $31
Current: $24.96
Upside: +24.20%
IDEXX Laboratories
Mar 31, 2026
Maintains: Buy
Price Target: $775 → $675
Current: $568.30
Upside: +18.78%
Tandem Diabetes Care
Feb 20, 2026
Maintains: Hold
Price Target: $20 → $22
Current: $18.63
Upside: +18.09%
Align Technology
Feb 5, 2026
Maintains: Buy
Price Target: $200 → $210
Current: $177.28
Upside: +18.46%
Insulet
Feb 4, 2026
Maintains: Buy
Price Target: $370 → $350
Current: $182.87
Upside: +91.39%
ResMed
Jan 30, 2026
Maintains: Hold
Price Target: $260 → $265
Current: $217.14
Upside: +22.04%
The Cooper Companies
Dec 5, 2025
Reiterates: Buy
Price Target: $85 → $95
Current: $63.09
Upside: +50.58%
Nov 18, 2025
Maintains: Hold
Price Target: $140 → $130
Current: $116.65
Upside: +11.44%
Oct 21, 2025
Reinstates: Hold
Price Target: $9
Current: $7.18
Upside: +25.35%
Oct 21, 2025
Reinstates: Buy
Price Target: $85
Current: $59.32
Upside: +43.29%
Sep 24, 2025
Maintains: Buy
Price Target: $18 → $23
Current: $22.15
Upside: +3.84%
Aug 8, 2025
Maintains: Hold
Price Target: $19 → $17
Current: $11.78
Upside: +44.31%
Jul 25, 2025
Downgrades: Hold
Price Target: $80 → $75
Current: $76.12
Upside: -1.47%
Feb 27, 2025
Maintains: Neutral
Price Target: $13 → $15
Current: $23.32
Upside: -35.68%
Jul 26, 2024
Maintains: Hold
Price Target: $4 → $2
Current: $0.84
Upside: +139.38%
Nov 27, 2023
Reiterates: Buy
Price Target: $17
Current: $3.01
Upside: +464.78%
May 12, 2020
Maintains: Buy
Price Target: $5 → $4
Current: $1.05
Upside: +280.95%
Aug 3, 2018
Maintains: Hold
Price Target: $32 → $35
Current: $119.63
Upside: -70.74%